Sven� Mahner

13.0k total citations · 1 hit paper
337 papers, 6.2k citations indexed

About

Sven� Mahner is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Sven� Mahner has authored 337 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Reproductive Medicine, 99 papers in Obstetrics and Gynecology and 75 papers in Surgery. Recurrent topics in Sven� Mahner's work include Ovarian cancer diagnosis and treatment (151 papers), Endometrial and Cervical Cancer Treatments (71 papers) and Intraperitoneal and Appendiceal Malignancies (38 papers). Sven� Mahner is often cited by papers focused on Ovarian cancer diagnosis and treatment (151 papers), Endometrial and Cervical Cancer Treatments (71 papers) and Intraperitoneal and Appendiceal Malignancies (38 papers). Sven� Mahner collaborates with scholars based in Germany, Austria and Belgium. Sven� Mahner's co-authors include Fabian Trillsch, Jalid Sehouli, Udo Jeschke, Ignace Vergote, Elena Ioana Braicu, Fritz Jaenicke, Philipp Harter, Robert Zeillinger, Linn Woelber and Andreas du Bois and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Sven� Mahner

317 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer

2024 98 citations Sven� Mahner, Stefan Kommoss et al. profile →

Peers

Countries citing papers authored by Sven� Mahner

Since Specialization

Citations

This map shows the geographic impact of Sven� Mahner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven� Mahner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven� Mahner more than expected).

Fields of papers citing papers by Sven� Mahner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven� Mahner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven� Mahner. The network helps show where Sven� Mahner may publish in the future.

Co-authorship network of co-authors of Sven� Mahner

This figure shows the co-authorship network connecting the top 25 collaborators of Sven� Mahner. A scholar is included among the top collaborators of Sven� Mahner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven� Mahner. Sven� Mahner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group – Real-world observations 2025 ·European Journal of Surgical Oncology ·Pauline Wimberger, Jacobus Pfisterer, Andreas du Bois, Felix Hilpert, (unknown), Jalid Sehouli, Sven� Mahner, Nikolaus de Gregorio, Lars Hanker, Florian Heitz, Frederik Marmé, Linn Wölber, (unknown), (unknown), Philipp Harter	0
2	Necroptosis-Related Gene Signature Predicts Prognosis in Patients with Advanced Ovarian Cancer 2025 ·Cancers ·Mingjun Zheng, Mirjana Kessler, Udo Jeschke, (unknown), Bastian Czogalla, (unknown), (unknown), Alexander Burges, Sven� Mahner, Fabian Trillsch, Till Kaltofen	1
3	Association of Four Interleukin-8 Polymorphisms (−251 A>T, +781 C>T, +1633 C>T, +2767 A>T) with Ovarian Cancer Risk: Focus on Menopausal Status and Endometriosis-Related Subtypes 2024 ·Biomedicines ·Rafał Watrowski, Eva Schuster, Gerda Hofstetter, Michael B. Fischer, Sven� Mahner, Toon Van Gorp, Stephan Polterauer, Robert Zeillinger, Eva Obermayr	4
4	POSTER 17The cytokines IL-1b and IL-18 are upregulated in the placenta of recurrent miscarriage patients 2023 ·Journal of Reproductive Immunology ·(unknown), Theresa� Vilsmaier, Elisa Schmoeckel, Sven� Mahner, Achim Wöckel, Udo Jeschke	1
5	Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSI 2022 ·Archives of Gynecology and Obstetrics ·Nina Rogenhofer, Udo Jeschke, Viktoria von Schönfeldt, Sven� Mahner, Christian J. Thaler	1
6	Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2 2022 ·International Journal of Molecular Sciences ·Sarah Meister, (unknown), Susanne Beyer, (unknown), Carolin Perleberg, (unknown), David Anz, Stefanie Corradini, Elisa Schmoeckel, Doris Mayr, Uwe Hasbargen, (unknown), Sven� Mahner, Udo Jeschke, Thomas Kolben	12
7	Gal-2 Increases H3K4me3 and H3K9ac in Trophoblasts and Preeclampsia 2022 ·Biomolecules ·(unknown), Sarah Meister, (unknown), Susanne Beyer, Stefanie Corradini, Uwe Hasbargen, Sven� Mahner, Udo Jeschke, Thomas Kolben, Alexander Burges	7
8	Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer 2021 ·International Journal of Molecular Sciences ·(unknown), Aurelia Vattai, Elisa Schmoeckel, Till Kaltofen, Anca Chelariu-Raicu, Mingjun Zheng, Sven� Mahner, Doris Mayr, Udo Jeschke, Fabian Trillsch	7
9	Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer 2021 ·Cancers ·Mingjun Zheng, Junyu Long, Anca Chelariu-Raicu, (unknown), Theresa� Vilsmaier, Aurelia Vattai, Helene Hildegard Heidegger, (unknown), (unknown), Udo Jeschke, Fabian Trillsch, Sven� Mahner, Till Kaltofen	19
10	Functional Analysis of Non-Genetic Resistance to Platinum in Epithelial Ovarian Cancer Reveals a Role for the MBD3-NuRD Complex in Resistance Development 2021 ·Cancers ·(unknown), (unknown), Till Kaltofen, (unknown), (unknown), (unknown), (unknown), Stephan A. Eisler, Sven� Mahner, (unknown), Stefan Kommoss, Annette Staebler, Lewis W. Francis, R. Steven Conlan, Johannes Zuber, Udo Jeschke, Fabian Trillsch, Philipp Rathert	8
11	A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer 2021 ·Cancers ·(unknown), Elena Ioana Braicu, Mitja Lääperi, Antti Jylhä, Sinikka Oksa, Sakari Hietanen, Jalid Sehouli, Hagen Kulbe, Andreas du Bois, Sven� Mahner, Philipp Harter, Olli Carpén, Kaisa Huhtinen, Johanna Hynninen, Mika Hilvo	10
12	Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer—A Study of the OVCAD Consortium 2021 ·Cancers ·Eva Obermayr, Elena Ioana Braicu, Stephan Polterauer, Liselore Loverix, Nicole Concin, Linn Woelber, Sven� Mahner, Jalid Sehouli, Toon Van Gorp, Ignace Vergote, Robert Zeillinger, Stefanie Aust	4
13	Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group 2021 ·Journal of Gynecologic Oncology ·Fabian Trillsch, Sven� Mahner, Bastian Czogalla, Miriam Rottmann, Radoslav Chekerov, Elena Ioana Braicu, (unknown), Pauline Wimberger, Rolf Richter, Jalid Sehouli	8
14	tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression 2021 ·Cancers ·Konstantina Panoutsopoulou, Tobias Dreyer, Julia Dorn, Eva Obermayr, Sven� Mahner, Toon Van Gorp, Elena Ioana Braicu, Robert Zeillinger, Viktor Magdolen, Margaritis Avgeris, Andreas Scorilas	40
15	Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile 2020 ·International Journal of Molecular Sciences ·Mingjun Zheng, (unknown), Anna Hester, Bastian Czogalla, Helene Hildegard Heidegger, Theresa� Vilsmaier, Aurelia Vattai, Anca Chelariu-Raicu, Udo Jeschke, Fabian Trillsch, Sven� Mahner, Till Kaltofen	34
16	Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer 2020 ·Journal of Cancer Research and Clinical Oncology ·Till Kaltofen, (unknown), (unknown), (unknown), Helene Hildegard Heidegger, Theresa� Vilsmaier, Aurelia Vattai, Bastian Czogalla, Doris Mayr, Sven� Mahner, Udo Jeschke, Fabian Trillsch	5
17	<p>Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology</p> 2019 ·Cancer Management and Research ·Bastian Czogalla, (unknown), Doris Mayr, Elisa Schmoeckel, Beate Niesler, Anna Hester, (unknown), Thomas Kolben, Alexander Burges, Sven� Mahner, Udo Jeschke, Fabian Trillsch	14
18	Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses 2016 ·Clinical Cancer Research ·Adriaan Vanderstichele, Pieter Busschaert, Dominiek Smeets, C. Landolfo, Els Van Nieuwenhuysen, Karin Leunen, Patrick Neven, Frédéric Amant, Sven� Mahner, Elena Ioana Braicu, (unknown), An Coosemans, D. Timmerman, Diether Lambrechts, Ignace Vergote	78
19	Chromosomal instability in cell-free DNA as a highly specific biomarker for ovarian cancer detection 2016 ·International Journal of Gynecological Cancer ·Adriaan Vanderstichele, Pieter Busschaert, Dominiek Smeets, Els Van Nieuwenhuysen, Karin Leunen, Patrick Neven, Frédéric Amant, Sven� Mahner, Elena Ioana Braicu, Robert Zeillinger, An Coosemans, D. Timmerman, Diether Lambrechts, Ignace Vergote	2
20	ICON7: FINAL OVERALL SURVIVAL RESULTS IN THE GCIG PHASE III RANDOMISED TRIAL OF BEVACIZUMAB IN NEWLY DIAGNOSED OVARIAN CANCER 2013 ·UCL Discovery (University College London) ·Éric Pujade-Lauraine, (unknown), Timothy Perren, (unknown), Sven� Mahner, (unknown), Susanne Malander, M. Plante, Philip Beale, Andrés Poveda, Rachel M. Kaplan, (unknown), M.K.B. Parmar	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact